| Date Filed | Type | Description |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 06/08/2023 |
4
| ADAMS STREET PARTNERS LLC (10% Owner) has filed a Form 4 on Rimini Street, Inc.|
Txns:
| Exercised 45,918 restricted stock units
@ $0
Granted 40,178 restricted stock units
@ $0 |
|
| 05/15/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 03/30/2023 |
4/A
| ADAMS STREET PARTNERS LLC (10% Owner) has filed a Form 4 on Rimini Street, Inc.|
Txns:
| Granted 45,918 restricted stock units
@ $0 |
|
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 12/21/2022 |
SC 13D/A
| ADAMS STREET PARTNERS LLC has filed a Schedule 13D for Icosavax, Inc. |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/17/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/15/2022 |
4
| ADAMS STREET PARTNERS LLC (10% Owner) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $0.965, valued at
$14.5k
|
|
| 06/03/2022 |
4
| ADAMS STREET PARTNERS LLC (10% Owner) has filed a Form 4 on Rimini Street, Inc.|
Txns:
| Exercised 27,565 restricted stock units
@ $0
Granted 27,522 restricted stock units
@ $0 |
|
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/15/2022 |
40-APP/A
| Form 40-APP/A - Application for exemption and other relief filed under the Investment Company Act of 1940: [Amend] |
| 02/14/2022 |
SC 13D/A
| ADAMS STREET PARTNERS LLC reports a 27.2% stake in Rimini Street Inc. |
| 02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
SC 13G/A
| ADAMS STREET PARTNERS LLC reports a 6.8% stake in Fusion Pharmaceuticals Inc. |
| 02/14/2022 |
SC 13G
| ADAMS STREET PARTNERS LLC reports a 7.7% stake in Vacasa, Inc. |
| 11/15/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 09/13/2021 |
4
| ADAMS STREET PARTNERS LLC (10% Owner) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $2.6, valued at
$39k
|
|
| 09/01/2021 |
40-APP/A
| Form 40-APP/A - Application for exemption and other relief filed under the Investment Company Act of 1940: [Amend] |
| 08/13/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/12/2021 |
SC 13D
| ADAMS STREET PARTNERS LLC has filed a Schedule 13D for Icosavax, Inc. |
| 08/03/2021 |
4
| ADAMS STREET PARTNERS LLC (Former 10% Owner) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Converted 948,188 shares
@ $0
Bought 47,981 shares
@ $15, valued at
$719.7k
Converted 916,558 shares
@ $0
Bought 46,381 shares
@ $15, valued at
$695.7k
Converted 272,131 shares
@ $0
Converted 352,037 shares
@ $0
Converted 525,729 shares
@ $0
Bought 26,604 shares
@ $15, valued at
$399.1k
Converted 244,415 shares
@ $0
Bought 12,368 shares
@ $15, valued at
$185.5k
Converted 3,631,066 preferred shares
@ $0 |
|
| 07/28/2021 |
3
| ADAMS STREET PARTNERS LLC (10% Owner) has filed a Form 3 on Icosavax, Inc. |
| 06/16/2021 |
4
| ADAMS STREET PARTNERS LLC (10% Owner) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $2.74, valued at
$41.1k
|
|
| 06/04/2021 |
4
| ADAMS STREET PARTNERS LLC (10% Owner) has filed a Form 4 on Rimini Street, Inc.|
Txns:
| Exercised 16,375 restricted stock units
@ $0
Granted 27,565 restricted stock units
@ $0 |
|
| 05/10/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 03/11/2021 |
4
| ADAMS STREET PARTNERS LLC (10% Owner) has filed a Form 4 on Rimini Street, Inc.|
Txns:
| Sold 41,426 shares
@ $7.37, valued at
$305.3k
Sold 46,695 shares
@ $7.37, valued at
$344.1k
Sold 40,911 shares
@ $7.37, valued at
$301.5k
|
|
| 02/11/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/10/2021 |
SC 13G
| ADAMS STREET PARTNERS LLC reports a 8.4% stake in Fusion Pharmaceuticals Inc. |
| 01/05/2021 |
4
| ADAMS STREET PARTNERS LLC (10% Owner) has filed a Form 4 on Rimini Street, Inc.|
Txns:
| Exercised 38,167 restricted stock units
@ $0
Granted 16,375 restricted stock units
@ $0 |
|
| 12/29/2020 |
4
| ADAMS STREET PARTNERS LLC (10% Owner) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 611 shares
@ $12.32, valued at
$7.5k
Sold 469 shares
@ $12.32, valued at
$5.8k
Sold 455 shares
@ $12.32, valued at
$5.6k
Sold 681 shares
@ $12.32, valued at
$8.4k
Sold 1,584 shares
@ $12.32, valued at
$19.5k
|
|
| 12/28/2020 |
4
| ADAMS STREET PARTNERS LLC (10% Owner) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 734 shares
@ $12.39, valued at
$9.1k
Sold 564 shares
@ $12.39, valued at
$7k
Sold 547 shares
@ $12.39, valued at
$6.8k
Sold 819 shares
@ $12.39, valued at
$10.1k
Sold 1,905 shares
@ $12.39, valued at
$23.6k
|
|
| 11/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 10/02/2020 |
4
| ADAMS STREET PARTNERS LLC (10% Owner) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 4,623 options to buy
@ $3.38, valued at
$15.6k
|
|
|